Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 1
1991 1
1993 2
1994 1
2002 1
2007 1
2008 1
2017 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.
Pujade-Lauraine E, Ledermann JA, Selle F, Gebski V, Penson RT, Oza AM, Korach J, Huzarski T, Poveda A, Pignata S, Friedlander M, Colombo N, Harter P, Fujiwara K, Ray-Coquard I, Banerjee S, Liu J, Lowe ES, Bloomfield R, Pautier P; SOLO2/ENGOT-Ov21 investigators. Pujade-Lauraine E, et al. Lancet Oncol. 2017 Sep;18(9):1274-1284. doi: 10.1016/S1470-2045(17)30469-2. Epub 2017 Jul 25. Lancet Oncol. 2017. PMID: 28754483 Free article. Clinical Trial.
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial.
Poveda A, Floquet A, Ledermann JA, Asher R, Penson RT, Oza AM, Korach J, Huzarski T, Pignata S, Friedlander M, Baldoni A, Park-Simon TW, Tamura K, Sonke GS, Lisyanskaya A, Kim JH, Filho EA, Milenkova T, Lowe ES, Rowe P, Vergote I, Pujade-Lauraine E; SOLO2/ENGOT-Ov21 investigators. Poveda A, et al. Lancet Oncol. 2021 May;22(5):620-631. doi: 10.1016/S1470-2045(21)00073-5. Epub 2021 Mar 18. Lancet Oncol. 2021. PMID: 33743851 Clinical Trial.
Treatment guidelines in ovarian cancer.
Poveda Velasco A, Casado Herráez A, Cervantes Ruipérez A, Gallardo Rincón D, García García E, González Martín A, López García G, Mendiola Fernández C, Ojeda González B; GEICO Group. Poveda Velasco A, et al. Among authors: ojeda gonzalez b. Clin Transl Oncol. 2007 May;9(5):308-16. doi: 10.1007/s12094-007-0058-8. Clin Transl Oncol. 2007. PMID: 17525041
A phase II trial of fixed-dosed rate gemcitabine in platinum-resistant ovarian cancer: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) Trial.
Ojeda Gonzalez B, Gonzalez Martin A, Bover Barcelo I, Fabregat i Mayol X, Mellado B, Rubio Perez MJ, Alonso Carrion L, Casado Herraez A, Calvo Garcia E, Churruca Galaz C, Arcusa Lanza A, Herrero Ibañez A, Adrover Cebrian E, Poveda Velasco A. Ojeda Gonzalez B, et al. Am J Clin Oncol. 2008 Oct;31(5):481-7. doi: 10.1097/COC.0b013e31816d1c7b. Am J Clin Oncol. 2008. PMID: 18838886 Clinical Trial.
[Locoregional recurrences after conservative treatment of breast cancer stage I-II].
Fuentes Raspall MJ, Piedrafita Serra E, Isern Verdum J, Alonso Muñoz C, Ojeda González B, Gómez Gómez A, Llauradó Ollé A, Duarte Pires D, Lerma Puertas E, Craven-Bartle Lamote De Grignon J, López López A, Trias Folch M. Fuentes Raspall MJ, et al. Among authors: ojeda gonzalez b. Med Clin (Barc). 2002 Feb 16;118(5):161-5. doi: 10.1016/s0025-7753(02)72321-x. Med Clin (Barc). 2002. PMID: 11851990 Spanish.
[Ductal carcinoma in situ of the breast].
Rueda Domínguez A, Alonso Muñoz MC, Gómez Gómez A, Ojeda González B. Rueda Domínguez A, et al. Among authors: ojeda gonzalez b. Med Clin (Barc). 1993 Oct 30;101(14):548-56. Med Clin (Barc). 1993. PMID: 8231402 Review. Spanish. No abstract available.
[Lobular carcinoma in situ of the breast].
Llanos Muñoz M, Alonso Muñoz MC, Ojeda González B. Llanos Muñoz M, et al. Among authors: ojeda gonzalez b. Med Clin (Barc). 1994 Oct 29;103(14):553-6. Med Clin (Barc). 1994. PMID: 7799670 Review. Spanish. No abstract available.
[The clinico-mammographic follow-up of breast cancer after conservative treatment].
Climent Durán MA, Gómez Gómez A, Seguí Palmer MA, Blanco Guerrero R, De Marco Izquierdo JA, Rueda Domínguez A, Fuentes Raspall J, Ojeda González B, Alonso Muñoz MC. Climent Durán MA, et al. Among authors: ojeda gonzalez b. Rev Clin Esp. 1993 Apr;192(7):309-14. Rev Clin Esp. 1993. PMID: 8497736 Spanish.
11 results